ArticleBlood advances2019

Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.

Elodie Pramil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.